Showing posts with label pharma. Show all posts
Showing posts with label pharma. Show all posts

Thursday, July 5, 2012

How Much Control Do We Have Over Our Brains?

There is a significant trend in neuroscience, and maybe even more so among the commentators who use that science to justify their political or social beliefs, of denying that we are really responsible for our own behavior. The usual argument goes like this: when a person does X, their brain scans light up in a certain way. People with brain damage to that area don't do X, or do it differently. Therefore we don't really have control of ourselves, our decisions or beliefs are just a function of our anatomy. I have written critically about these Just-So Science Stories here. Other writers (ok, better writers), in a political context, have pointed out that some liberal social scientists have started using this same approach to define conservatism as a disease.


However, just because science can be manipulated to support certain dubious conclusions doesn't mean there isn't a lot of interesting work being done in understanding how the brain works. And one such finding has to do with how a parasite in our brains might be responsible for our positive reactions to the scents of certain wines and perfumes. As writer Patrick House puts it:
Why is it that the elite French perfumers (known as “noses”) and sommeliers (“upturned noses”) of the world spend so much of their time inhaling cat effluvia from expensive glass bottles? A guess: It may have to do with a mind-control parasite called Toxoplasma gondii. The tiny protozoan may be getting into our brains and tricking us into liking cats—not to mention certain perfumes and wines.
In a recent study, Czech scientists gave men and women towels scented with the urine of various animals—horses, lions, hyenas, cats, dogs—which they rated for “pleasantness.” Turns out, men who tested positive for Toxo found the smell of cat urine more pleasant than men without Toxo. For Toxo researchers like me, this was a shock but not entirely surprising. Why? Toxo does approximately the same thing to rats.
You'll have to read the article to get the full theory of why Toxo does what it does, but the implications are staggering: a single-celled organism might be altering way our brain processes information from our senses. Think of it: could we find a bacteria that lowers the speed at which our neurons fire, influencing how fast we remember or respond to stimuli? Could we find a parasite that alters our hearing our sight?

Or think of the commercial issues. Some perfume and wine companies would presumably do better if more people were infected by Toxo. Maybe Chanel will start working with animal adoption organizations to try to get cats into more homes, increasing their likely customer base.

If we begin to discover that some significant portion of the way we perceive the world is influenced by outside organisms, will we attempt to purge them all to standardize the way the human mind works? Will we search for those with favorable impacts and try to infect everyone with them? Could this be the next frontier in pharmaceutical development? Or is this a one-off, and our mental machinery is basically unaltered by microscopic invaders? I guess we just have to wait and see.

Tuesday, April 24, 2012

Apple Gets an FDA Letter

April 23, 2012

Mr. Tim Cook
CEO, Apple Inc
1 Infinite Loop
Cupertino, CA 95014

Mr. Cook:

As I hope you are aware, under USC Title 15, Chapter 48, Section 2101, Congress has expanded the FDA's regulatory powers to cover all businesses that a consumer could reasonably (or unreasonably) believe are in some way involved in the production or distribution of ingested substances. Obviously, a company named Apple is now well within our purview. (And, if I may be frank with you, the use of a business name that creates the expectation of nutritional value when none is provided may, in and of itself, be the violation of several key regulations.)

However, it is my purpose today to provide a warning about Apple's current non-compliant marketing practices, hereafter to be referred to as NCMPs, and an order to cease and desist all such practices immediately. As these issues may be unfamiliar to a businessman who has not had previous dealings, I would encourage you to discuss the contents of this letter (subject to the counsel of your internal legal department) with executives from any pharmaceutical company, who are more than familiar with these regulations and how to comply with them.

Topic A: Promotion of product feature "Siri" included with Apple iPhone 4s

Our regulators have been deeply disturbed by numerous NCMPs associated with your introduction of "Siri". First, our scientific advisors challenge the often-repeated notion that this application represents "artificial intelligence" in any meaningful way. The literature on AI is well-established, and establishing that a device demonstrates it requires, at minimum, that it pass a Turing Test.  As there is no evidence Siri has done so, you are hereby not allowed to use this phrasing, or any similar phrasing, in promotional messages. Additionally, it is an NCMP to refer to Siri as a "personal assistant", as this implies human characteristics and abilities that it cannot possess. (You may use the word "assist" to describe the applications MOA.) To avoid any possible confusion, all television advertisements depicting human users easily and naturally interacting with Siri are deemed not compliant and must be removed from all media immediately. Finally, there is a lack of fair balance in your Siri-related communications. To avoid future NCMPs, you must include the rate at which Siri misinterprets commands given to it, and any possible safety risks associated with such errors.

Topic B: Promotion of "The New iPad"

First, we find the naming of the iPad problematic, and ask you to find a more suitable name within 90 days to avoid the product being withdrawn from the market and the levying of significant financial penalties. As you should realize, there is a high risk of confusion between the iPad and the iPod, which is a completely distinct product with a different indication. Without being too prescriptive, we would suggest that a name like "TouchTablet" would be more clear, and thus in the best interests of users. Additionally, it is a significant NCMP to use the neologism "Resolutionary" to promote the product. The obvious intent is to imply that this is a revolutionary product, when most experts believe that a sharper screen and better cameras represent, at best, an incremental improvement over previous models

Topic C: The Apple Store

An audit of your retail locations has unearthed a number of violations that must be addressed immediately. First, it seems you have been offering free setup of your products for some time, which is an obvious NCMP. Any incentive to purchase a product other than offering certain permitted discounts is a violation of regulations. Second, you are henceforth no longer permitted to call your technical support area a "Genius Bar" unless you can document that the average IQ of your support staff is over 135.

We find that these are the most severe regulatory violations, although we would strongly suggest you establish a registry to help investigators determine whether, as some initial studies indicate, your iPhone products are in fact addictive.

The attached 274 page form should help you get started in your reply to this letter. We look forward to working with you to clear up these violations, and ensure, for the good of the consumer, that your future marketing efforts are conducted in a more thoughtful and balanced way.

Sincerely,

Dan Reed
High Inquisitor for Ridiculously Regulated Products


Editor's Note: I have fortunately never received an FDA letter myself, and I'm sure they're a bit more nuanced than my parody. But all of these theoretical violations on Apple's part do parallel the type of rules that pharmaceutical companies have to comply with when they want to talk about their products. So here's my question for my readers: do you think strictly limiting communications in this way actually helps consumers? Or, as I believe, do these rules actually makes it harder to communicate clearly about how health products can help people?